Products and Processes for Multiplex Nucleic Acid Identification
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/US2012/038710, filed May 18, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 10,604,791 | Products and Processes for Multiplex Nucleic Acid Identification In force · Medium confidence | Agena Bioscience, Inc. | In force | Medium confidence | ||
| US 11,667,958 | Products and Processes for Multiplex Nucleic Acid Identification In force · Medium confidence | Agena Bioscience, Inc. | In force | Medium confidence | ||
| US 12,630,865 | Products and Processes for Multiplex Nucleic Acid Identification In force · Medium confidence | Agena Bioscience, Inc. | In force | Medium confidence | ||
| Application 13/790,996 | Products and Processes for Multiplex Nucleic Acid Identification Abandoned Abandoned Aug 14, 2019 | Agena Bioscience, Inc. | Abandoned | Abandoned Aug 14, 2019 |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Agena Bioscience, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.